Chemoinformaics analysis of Docosanoic acid 1-methyl-butyl ester
| Molecular Weight | 410.727 | nRot | 23 |
| Heavy Atom Molecular Weight | 356.295 | nRig | 1 |
| Exact Molecular Weight | 410.412 | nRing | 0 |
| Solubility: LogS | -7.512 | nHRing | 0 |
| Solubility: LogP | 10.82 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 82.7008 |
| nHD | 0 | BPOL | 56.7772 |
| QED | 0.124 |
| Synth | 2.529 |
| Natural Product Likeliness | 0.271 |
| NR-PPAR-gamma | 0.244 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -5.002 |
| MDCK | 0.00000625 |
| BBB | 0.018 |
| PPB | 0.978914 |
| VDSS | 3.266 |
| FU | 0.0132391 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.148 |
| CYP2c19-inh | 0.138 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.053 |
| CYP2c9-sub | 0.972 |
| CYP2d6-inh | 0.091 |
| CYP2d6-sub | 0.016 |
| CYP3a4-inh | 0.221 |
| CYP3a4-sub | 0.031 |
| CL | 4.67 |
| T12 | 0.046 |
| hERG | 0.361 |
| Ames | 0.002 |
| ROA | 0.008 |
| SkinSen | 0.971 |
| Carcinogencity | 0.031 |
| EI | 0.9 |
| Respiratory | 0.696 |
| NR-Aromatase | 0.096 |
| Antiviral | No |
| Prediction | 0.528914 |